Nesplora company

Nesplora develops software tools in virtual reality environments for the evaluation of various neurological pathologies. It offers a disruptive conception of evaluating human cognition and behavior using standardized and scientifically validated virtual reality scenarios. The company has revolutionized the evaluation of behavior and cognition, making it more scientific, functional and objective. Nesplora has received EU funding from Phase 1 and 2 of Horizon 2020’s SME Instrument. Nesplora products are scientific tests, all scaled, contrasted and validated. Currently, these measurements are made with pencil and paper, with pseudo-objective tests or with subjective questionnaires to the family or the patient. They design and develop innovative tools to improve the diagnosis of patients with such far-reaching and universal problems as Alzheimer's, mental illness, brain damage of any etiology or developmental problems.
Technology: NeuroTech
Industry: Health Care, Sports
Headquarters: Donostia-san Sebastián, Pais Vasco, Spain
Founded Date: 2009-01-01
Employees Number: 11-50
Investors Number: 1
Total Funding: €1.5M
Last Funding Type: Grant

Visit Website
info@nesplora.com
https://www.twitter.com/nesplora
Register and Claim Ownership